Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations
- PMID: 3172810
Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations
Abstract
This study examined the effect of changes in plasma concentrations of total protein, albumin, alpha 1-acid glycoprotein, and free fatty acids occurring after heart operations on the protein binding of chemically basic drugs. Plasma protein and free fatty acid concentrations were measured simultaneously with in vitro determinations of the protein binding of lidocaine, quinidine, and propranolol: immediately before operation, immediately on weaning from cardiopulmonary bypass, on arrival in the recovery room, and 12, 24, 72, and 120 hours postoperatively. Initial decreases in the concentrations of all proteins were followed by a rise in alpha 1-acid glycoprotein to 254% of baseline at 72 to 120 hours. The free fractions of drug were initially increased to 168% of baseline for lidocaine, 206% for quinidine, and 200% for propranolol and fell progressively with time, reaching sustained troughs of 65% for lidocaine, 50% for quinidine, and 57% for propranolol at 72 to 120 hours. Regression analysis indicated a major influence of changing alpha 1-acid glycoprotein concentrations on free fractions of all three drugs, with a smaller effect of albumin that reached statistical significance only for lidocaine. There were no significant perioperative changes in plasma concentrations of free fatty acids when the in vitro effects of heparin were controlled. In conclusion, sequential changes in plasma protein concentrations after cardiac operations predictably alter the protein binding of lidocaine, quinidine, and propranolol and should be considered when interpreting total plasma drug concentrations.
Similar articles
-
Factors influencing serum protein binding of lidocaine in humans.Anesth Analg. 1981 Jun;60(6):395-400. Anesth Analg. 1981. PMID: 6165258
-
Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.Int J Clin Pharmacol Ther Toxicol. 1985 Oct;23(10):535-9. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3934087
-
Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy.Br J Obstet Gynaecol. 1986 Apr;93(4):322-8. Br J Obstet Gynaecol. 1986. PMID: 3964607
-
Plasma drug binding: implications for anesthesiologists.Anesth Analg. 1986 Jul;65(7):786-804. Anesth Analg. 1986. PMID: 3087239 Review. No abstract available.
-
Individualization of dosage of antiarrhythmic drugs.Med Clin North Am. 1974 Sep;58(5):1019-26. doi: 10.1016/s0025-7125(16)32097-1. Med Clin North Am. 1974. PMID: 4609363 Review. No abstract available.
Cited by
-
Population pharmacokinetics of lidocaine administered during and after cardiac surgery.J Cardiothorac Vasc Anesth. 2011 Dec;25(6):931-6. doi: 10.1053/j.jvca.2011.03.008. Epub 2011 May 25. J Cardiothorac Vasc Anesth. 2011. PMID: 21616681 Free PMC article. Clinical Trial.
-
Effects of surgery on the pharmacokinetic parameters of drugs.Clin Pharmacokinet. 1998 Oct;35(4):293-312. doi: 10.2165/00003088-199835040-00003. Clin Pharmacokinet. 1998. PMID: 9812179 Review.
-
Pharmacokinetics of quinidine in male patients. A population analysis.Clin Pharmacokinet. 1992 Jun;22(6):468-80. doi: 10.2165/00003088-199222060-00005. Clin Pharmacokinet. 1992. PMID: 1587058
-
Nonlinear pharmacokinetics: clinical Implications.Clin Pharmacokinet. 1991 Jun;20(6):429-46. doi: 10.2165/00003088-199120060-00001. Clin Pharmacokinet. 1991. PMID: 2044328 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical